
Annual report 2024
added 04-25-2026
Nano-X Imaging Ltd. Retained Earnings 2011-2026 | NNOX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Nano-X Imaging Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -374 M | -320 M | -259 M | -146 M | -84.4 M | -40.6 M | -18 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -18 M | -374 M | -178 M |
Quarterly Retained Earnings Nano-X Imaging Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -146 M | - | - | - | -84.4 M | - | - | - | -40.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -40.6 M | -146 M | -90.4 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-380 M | - | - | $ 3.31 B | ||
|
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-217 M | $ 11.16 | -0.09 % | $ 316 M | ||
|
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-1.42 B | $ 8.27 | 0.55 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.33 | 0.23 % | $ 162 M | ||
|
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | ||
|
LENSAR
LNSR
|
-178 M | $ 5.86 | 1.03 % | $ 70.1 M | ||
|
Helius Medical Technologies
HSDT
|
-213 M | $ 2.31 | 6.94 % | $ 50.9 M | ||
|
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.47 | -0.53 % | $ 29.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 18.4 | 0.93 % | $ 432 M | ||
|
LivaNova PLC
LIVN
|
-1.15 B | $ 73.67 | 1.03 % | $ 4.02 B | ||
|
MiMedx Group
MDXG
|
-42.7 M | $ 3.77 | 3.43 % | $ 557 M | ||
|
Delcath Systems
DCTH
|
-529 M | $ 11.2 | 3.23 % | $ 401 M | ||
|
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-420 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.0 | -4.29 % | $ 16.9 M | ||
|
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
-522 M | $ 1.54 | 14.55 % | $ 62.7 M | ||
|
Electromed
ELMD
|
21.2 M | $ 37.58 | -2.06 % | $ 318 M | ||
|
Myomo
MYO
|
-119 M | $ 0.9 | 3.7 % | $ 37.7 M | ||
|
Butterfly Network
BFLY
|
-879 M | $ 4.42 | 7.8 % | $ 1.09 B | ||
|
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
-368 M | $ 12.16 | 0.58 % | $ 482 M | ||
|
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
-292 M | $ 2.19 | -0.45 % | $ 6.07 M | ||
|
Profound Medical Corp.
PROF
|
-288 M | $ 6.95 | 3.19 % | $ 210 M | ||
|
Globus Medical
GMED
|
1.39 B | $ 83.98 | 5.06 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
287 M | $ 157.2 | 1.68 % | $ 11.1 B | ||
|
CONMED Corporation
CNMD
|
589 M | $ 36.7 | 1.44 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
-146 M | $ 44.19 | 3.87 % | $ 1.3 B | ||
|
TransMedics Group
TMDX
|
-278 M | $ 68.79 | 4.01 % | $ 2.34 B | ||
|
Integer Holdings Corporation
ITGR
|
994 M | $ 91.17 | 0.81 % | $ 3.17 B | ||
|
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 82.96 | 0.97 % | $ 48.5 B |